Working with Latino Patients and Their Families: For Treatment ProfessionalsAsk The Expert

Original Air Date September 7, 2022 | 12:00 PM - 1:00 PM EDT


Luke Smith MD

View on YouTube 

Cultural norms and barriers to healthcare in Latino communities can affect the perception of ADHD symptoms in children. While Latino communities show similar susceptibility to ADHD as the general population, Latino children in the United States are less likely to be diagnosed and treated. Psychiatrist Luke Smith presents important cultural considerations professionals need to be aware of when treating Latinos who have ADHD.

Resources

El Futuro ADHD Program

Objectives

Upon completion of the webinar, you will be able to:

  • Understand contextual factors to acknowledge when talking with Latino families about medication
  • Identify styles and content that can promote and derail effective communication
  • Illustrate culturally appropriate metaphors that promote understanding

Presenter

David Lucas “Luke” Smith was raised in Arkansas and moved to North Carolina for training in child and adult psychiatry. After volunteering in the community and perceiving a great need for Spanish language services, Dr. Smith mobilized the community to create El Futuro. He is the executive director and medical director and provides psychiatric care to both children and adults. Each year, he and his staff provide services to 1,500–1,700 children and families who come for help. He is double board-certified in both adult psychiatry and in child and adolescent psychiatry. In addition to being active with direct services and shaping policy at the local and state level, Dr. Smith leads the organization in research efforts through projects funded by the NIMH and PCORI with a focus on creating evidence-based practices that are especially targeted to help the North Carolina Latino community.

For questions, please email training@chadd.org

This webinar is provided by CHADD’s National Resource Center on ADHD and is supported by Cooperative Agreement Number NU38DD005376 funded by the Centers for Disease Control and Prevention (CDC).